North American Intrauterine Contraceptive Devices (IUD/IUCD) Market
- Written by: Pitch Engine
Geographically, the U.S. contributed the maximum market share of around 93.0% in 2013 to the North American intra-uterine contraceptive devices market. This market was valued at $724.1 million in 2014, which is expected to reach a value of $734.4 million by 2019, at a CAGR of 0.3% from 2014 to 2019. In terms of growth potential, the Canadian market is an open market, and expected to witness maximum growth in the IUCD market during the forecast period. The Canadian intra-uterine contraceptive devices IUCD market was valued at $54.1 million in 2014, and is expected to reach a value of $55.4 million by 2019, at a CAGR of 0.5% from 2014 to 2019.
The report also provides a detailed competitive landscaping of the major companies operating in this market. Segment and country-specific company shares, news & deals, M&As, and segment-specific pipeline products, product approvals, and product recalls of the major companies have been detailed in this research report. The main companies operating in the North American market are Bayer HealthCare AG (Germany), Teva Pharmaceuticals Industries Ltd. (Israel), Actavis Plc. (Ireland), and Medicines360 (Ireland), among others.
Table Of Contents
1 Introduction (Page No. - 8) 1.1 Objectives Of The Study 1.2 Market Segmentation & Coverage
2 Research Methodology (Page No. - 11) 2.1 Integrated Ecosystem Of Intrauterine Contraceptive Devices Market 2.2 Arriving At The Intrauterine Contraceptive Devices Market Size 2.2.1 Top-Down Approach 2.2.2 Bottom-Up Approach 2.2.3 Macro Indicator-Based Approach 2.3 Assumptions
3 Executive Summary (Page No. - 16)
4 Market Overview (Page No. - 18) 4.1 Introduction 4.2 Market Drivers And Inhibitors 4.3 Key Market Dynamics
5 North America Intra-Uterine Contraceptive Devices Market, By Type (Page No. - 26) 5.1 Introduction 5.2 Copper Iud 5.3 Hormonal Iud 5.4 North America Intra-Uterine Contraceptive Devices Market,
5.5 North America Hormonal Iud Market, By Country 5.6 North America Copper Iud Market, By Country
6 North America Intra-Uterine Contraceptive Devices Market, By Product (Page No. - 32) 6.1 Mirena 6.1.1 Product Positioning And Promotions Of Mirena 6.2 Skyla 6.2.1 Product Positioning And Promotions Of Skyla 6.3 Paragard 6.3.1 Product Positioning And Promotions Of Paragard 6.4 Essure 6.4.1 Product Positioning And Promotions Of Essure 6.5 Pipeline Products 6.5.1 Levosert
7 North America Intra-Uterine Contraceptive Devices Market, (Page No. - 42)
7.1 Introduction 7.2 U.S. Intra-Uterine Contraceptive Devices Market 7.2.1 U.S. Intra-Uterine Contraceptive Devices (Iucd) Market, By Type 7.2.2 U.S. Intra-Uterine Contraceptive Devices Market, By Type 7.3 Canada Intra-Uterine Contraceptice Devices Market 7.3.1 Canada Intra-Uterine Contraceptive Devices Market, By Type
8 North America Intra-Uterine Contraceptive Devices Market: (Page No. - 51)
8.1 U.S. Intra-Uterine Contraceptive Devices Market: Company Share Analysis 8.2 Canada Intra-Uterine Contraceptive Devices Market: Company Share Analysis 8.3 Mergers & Acquisitions 8.4 Regulatory Approvals 8.5 Partnership 8.6 Collaboration
9 North America Intra-Uterine Contraceptive Devices Market, By Company (Page No. - 55) 9.1 Bayer Healthcare Ag (Subsidiary Of Bayer Ag) 9.2 Teva Pharmaceutical Industries Ltd. 9.3 Actavis Plc 9.4 Medicines360 9.5 Trimedic Supply Network Ltd. 9.6 Medisafe Distribution Inc. 9.7 Pace Pharmaceuticals, Inc.
10 Appendix (Page No. - 68) 10.1 Related Reports 10.2 Introducing Rt: Real Time Market Intelligence 10.2.1 Rt Snapshots
List Of Tables
Table 1 North America Intra-Uterine Contraceptive Devices Market: Macro Indicators, By Country, 2013 (Abortion Per 1000 Women Ages 15-44)Table 2 North America Intra-Uterine Contraceptive Devices Market: Drivers And InhibitorsTable 3 Global Intra-Uterine Contraceptive Devices Market: Comparision With Global Female Contraceptives Market, 2013–2019 (Usd Mn)Table 4 North America Intra-Uterine Contraceptive Devices Market, By Country,2013–2019 (Usd Mn) Table 5 North America Intra-Uterine Contraceptive Devices Market, By Typ,2013–2019 (Usd Mn) Table 6 North America Intra-Uterine Contraceptive Devices Market, By Type,2013–2019 (Usd Mn) Table 7 North America Intra-Uterine Contraceptive Devices Market: Type Comparison With Female Contraceptives Market, 2013–2019 (Usd Mn)Table 8 North America Hormonal Iud Market, By Country, 2013–2019 (Usd Mn)Table 9 North America Copper Iud Market, By Country, 2012 - 2018 (Usd Mn)Table 10 North America Intra-Uterine Contraceptive Devices Market, Bycountry, 2012 - 2018 (Usd Mn)Table 11 North America Intra-Uterine Contraceptive Devices Market, By Type,2012 - 2018 (Usd Mn) Table 12 U.S. Intra-Uterine Contraceptive Devices Market, By Type,2013-2019 (Usd Mn) Table 13 Canada Intra-Uterine Contraceptive Devices Market, By Type,2012 - 2018 (Usd Mn) Table 14 U.S. Intra-Uterine Contraceptive Devices Market: Company Share Analysis, 2013 (%)Table 15 Canada Intra-Uterine Contraceptive Devices Market: Company Share Analysis, 2013 (%)Table 16 North America Intra-Uterine Contraceptive Devices Market: Mergers & AcquisitionsTable 17 North America Intra-Uterine Contraceptive Devices Market: Regulatory ApprovalsTable 18 North America Intra-Uterine Contraceptive Devices Market: PartnershipTable 19 North America Intra-Uterine Contraceptive Devices Market: CollaborationTable 20 Bayer Healthcare Ag.: Key Financials, 2008 - 2013 (Usd Mn)Table 21 Teva Pharmaceutical Industries Ltd.: Key Financials, 2008 - 2013 (Usd Mn)Table 22 Actavis Plc: Key Financials, 2008 - 2013 (Usd Mn)
List Of Figures
Figure 1 Evolution Of IucdFigure 2 Widely Used Contraceptive MethodsFigure 3 North America Intra-Uterine Contraceptive Devices Market: Segmentation & CoverageFigure 4 Intrauterine Contraceptive Devices Market: Integrated EcosystemFigure 5 Top-Down ApproachFigure 6 Bottom-Up ApproachFigure 7 Macro Indicator-Based ApproachFigure 8 North America Intra-Uterine Contraceptive Devices Market SnapshotFigure 9 Birth Control Methods Covered Under Affordable Care Act (Aca)Figure 10 Global Intrauterine Contraceptive Devices Market: Comparison With Global Female Contraceptives MarketFigure 11 North America Intrauterine Contraceptive Devices, By Country,2013 (Usd Mn) Figure 12 North America Intrauterine Contraceptive Devices Market, By Type,2013 (Usd Mn) Figure 13 Advantages And Disadvantages Of Copper IucdFigure 14 Advantages And Disadvantages Of Hormonal IucdFigure 15 North America Intra-Uterine Contraceptive Devices Market, By Type,2012 - 2018 (Usd Mn) Figure 16 North America Intra-Uterine Contraceptive Devices Market: Type Comparison With Female Contraceptives Market, 2013–2019 (Usd Mn)Figure 17 North America Hormonal Iud Market, By Country, 2013–2019 (Usd Mn)Figure 18 North America Copper Iud Market, By Country, 2013–2019 (Usd Mn)Figure 19 Sales (Usd Million) Of Mirena, U.S., 2012Figure 20 Adverse Effects Caused By Mirena, U.S., 1997-2012Figure 21 Product Comparison Between Mirena And Skyla, U.S.Figure 22 Product Specifications, LevosertFigure 23 Average Selling Price (Usd) Of Marketed Intra-Uterine Contraceptive Devices (Iucd) In U.S. And Canada, 2013Figure 24 U.S. Intra-Uterine Contraceptive Devices Market Overview,2014 & 2019 (Usd Mn) Figure 25 U.S. Intra-Uterine Contraceptive Devices Market, By Type 2013-2019 (Usd Mn)Figure 26 Percentage Usage Of Various Contraceptive Devices , U.S., 2010Figure 27 Percentage Usage Of Various Contraceptive Devices , U.S., 2013Figure 28 Canada Intra-Uterine Contraceptive Devices Market Overview,2013 & 2018 (%) Figure 29 Canada Intra-Uterine Contraceptive Devices Market, By Type,2012-2018 (Usd Mn) Figure 30 U.S. Intra-Uterine Contraceptive Devices Market: Company Share Analysis, 2013 (%)Figure 31 Canada Intra-Uterine Contraceptive Devices Market: Company Share Analysis, 2013 (%)Figure 32 Bayer Healthcare Ag: Revenue Mix (2013) (%)Figure 33 Contribution Of Pharmaceuticals Segment Towards Company Revenues, 2008-2013 (Usd Mn)Figure 34 Teva Pharmaveutical Industries Ltd.: Revenue Mix (2013) (%)Figure 35 Contribution Of Speciality Medicine Segment Towards Company Revenues, 2008-2013 (Usd Mn)Figure 36 Actavis Plc: Revenue Mix (2013) (%)
Authors: Pitch Engine
Read more http://www.pitchengine.com/pitches/26e7416b-941d-4360-94a0-eb3ef2155cdf
Daily Bulletin
